The British financial institution issued 623 structured products in the US for the first quarter of 2020, the highest issuance figure since Q1 19, reaching record sales volumes of US$3.54 billion. This compares with 429 products totalling US$1.51 billion in the same quarter a year prior.

Group net profits slid by 35% from the first quarter of 2019 totalling £842 million from US$1.24 billion while total income saw a 20% increase from Q1 19 boasting figures of £6.28 billion from £5.25 billion. In response to the Covid-19 outbreak, the bank has welcomed support from both the government and the Bank of England, and has introduced additional measures to back UK companies. As of 24 April 2020, Barclays facilitated significant commercial paper issuance through the Covid Corporate Fin

Continue reading and get unlimited access for 7 days with a free trial of SRP.

Get a free trial

Already a subscriber? Login